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sites	 from	 around	 the	 UK	 (including	 the	 devolved	 nations	 of	 Wales	 and	 Scotland),	
between	2007	and	2013.	Controls	 included	 family	 and	 friends	of	 those	attending	ENT	
outpatient	 clinics	 and	 hospital	 staff	who	 had	 no	 diagnosis	 of	 persistent	 nose	 or	 sinus	
































SNOT-22	 Nasal	 Facial	 Sleep	
fatigue	
Emotional	
	 n	 	 mean	(sd)	 Median	
(IQR)	
mean	(sd)	 mean	(sd)	 mean	(sd)	 mean	(sd)	
Total	 251	 47.5		
(19-80)	








10.2	(11.1)	 6.5	(2-14.5)	 2.8	(4.4)	 0.7	(1.4)	 2.2	(2.7)	 3.0	(4.1)	
Differences	
(p	values)	






















a	 large	 number	 of	 individuals	who	 score	 very	 low	 (floor	 effect).	 Previous	 studies	 of	 a	
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